Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.50
Low: 6.25
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £215,113

6 Apr 2022 07:00

RNS Number : 3966H
Braveheart Investment Group plc
06 April 2022

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

6 April 2022

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

Placing to raise 拢215,113 before expenses

Braveheart Investment Group (AIM: BRH), is pleased to announce a placing of 1,434,091 new ordinary shares of 2 pence each in the Company ("Placing Shares") at a price of 15 pence per share ("Placing Price"), raising gross proceeds of 拢215,113 before expenses (the "Placing").

Highlights

Fundraise of 拢215,113, through a conditional placing by the Company's broker, Peterhouse Capital Limited, of 1,434,091 new ordinary shares of 2 pence each in the Company at an issue price of 15 pence per Placing Share.

The Placing Shares will represent approximately 2.67 per cent. of the enlarged issued share capital of the Company.

The Placing Shares are being issued at a price of 15 pence per Placing Share, representing a discount of 10 per cent. to the closing mid-market share price of an existing ordinary share on 5 April 2022 of 16.5p, the business day prior to this announcement.

The Company has utilised its existing authority to issue new ordinary shares for cash on a non-pre-emptive basis.

Trevor Brown, Chief Executive of the Company, has subscribed for 143,407 Placing Shares.

Trevor Brown, Braveheart CEO, commented: "We are delighted to have been able to raise this extra funding which will enable Braveheart to continue its investment in portfolio assets."

Director participation in the Placing

Trevor Brown, Chief Executive of the Company, has subscribed for 143,407 Placing Shares, at the issue price of 15 pence per ordinary share. Following completion of the Placing, Trevor Brown will hold 4,894,420 ordinary shares in the Company, equivalent to 9.12 per cent. of the Company's issued share capital as enlarged by the Placing. The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation, is appended below.

Details of the Placing and total voting rights

A total of 1,434,091 Placing Shares are to be issued at a price of 15 pence per share. The Placing has been conducted utilising the Company's existing share authorities granted at the Annual General Meeting of the Company held on 14 July 2021.聽Peterhouse Capital Limited acted as the Company's broker in connection with the Placing. Allenby Capital Limited acted as the Company's nominated adviser in connection with the Placing. The Placing is conditional,聽inter alia, on admission of the Placing Shares to trading on AIM ("Admission") becoming effective.

The net proceeds of the Placing will be used by the Company in order to be able to continue to support the Strategic Investments of the Company in their development and, if appropriate, for new investments and for working capital generally.

Application has been made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM. It is expected that Admission will become effective and that dealings in the Placing Shares on AIM will commence on or around 11 April 2022.

On Admission, the Company's issued ordinary share capital will consist of 53,674,431 ordinary shares of 2 pence each, with one vote per share. The Company does not hold any ordinary shares in treasury. Therefore, on Admission, the total number of ordinary shares and voting rights in the Company will be 53,674,431. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:聽

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown CEO

Allenby Capital Limited聽(Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge聽/聽James Reeve / George Payne

Peterhouse Capital Limited聽(Joint Broker)

Tel: 020 7469 0936

Heena Karani聽/聽Lucy Williams

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Trevor Brown

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Braveheart Investment Group plc

b)

LEI

2138006HQ3COMU626I61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2 pence each in Braveheart Investment Group plc

GB00B13XV322

b)

Nature of the transactions

Conditional placing of new ordinary shares

c)

Price(s) and volume(s)

Price(s)

15p

Volume(s)

143,407

d)

Aggregated information

- Aggregated volume

- Price

- Principal amount

143,407

15p

拢21,511.05

e)

Dates of the transaction

聽6 April 2022

f)

Place of transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEBELLBLZLXBBL
Date   Source Headline
24th Nov 20147:00 amRNSCrowdcube Fund makes first four investments
23rd Sep 20147:00 amRNSDirector/PDMR Shareholding
23rd Sep 20147:00 amRNSDirectorate Change
22nd Sep 20142:10 pmRNSResult of AGM
1st Sep 20147:00 amRNSNotice of AGM
29th Aug 20143:16 pmRNSTotal Voting Rights
27th Aug 20147:00 amRNSDirector/PDMR Shareholding
20th Aug 20147:00 amRNSDirector/PDMR Shareholding
20th Aug 20147:00 amRNSAward of options
19th Aug 20147:00 amRNSDirector/PDMR Shareholding
14th Aug 201412:04 pmRNSHolding(s) in Company
14th Aug 201412:04 pmRNSHolding(s) in Company
11th Aug 20147:00 amRNSIssue of Equity
22nd Jul 20143:52 pmRNSHolding(s) in Company
22nd Jul 20147:00 amRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSPreliminary Results
3rd Apr 20143:18 pmRNSHolding(s) in Company
3rd Apr 20141:32 pmRNSHolding(s) in Company
3rd Apr 20141:30 pmRNSHolding(s) in Company
1st Apr 20147:00 amRNSTotal Voting Rights
28th Mar 201411:29 amRNSAward for WhiteRock Capital Partners
25th Mar 20147:00 amRNSIssue of Equity and Directorate Change
31st Jan 20142:58 pmRNSTotal Voting Rights
31st Jan 20147:00 amRNSHolding(s) in Company
31st Jan 20147:00 amRNSHolding(s) in Company
27th Jan 20147:00 amRNSPartnership to launch co-investment fund
14th Jan 20147:00 amRNSIssue of Equity
18th Dec 20137:00 amRNSHalf Yearly Report
13th Dec 201312:29 pmRNSDisposal
11th Dec 20137:00 amRNSFinance Yorkshire Update
6th Dec 20137:00 amRNSWhiteRock Capital Partners update
26th Sep 20132:55 pmRNSResult of AGM
16th Sep 20137:00 amRNSEnvestors funds growth at FX firm Ebury Partners
4th Sep 20137:00 amRNSNotice of AGM
3rd Sep 20137:00 amRNSFinal Results
14th Aug 20137:00 amRNSWhiteRock Capital Partners update
26th Jul 20137:00 amRNSFirst exit from fund
11th Jun 20137:00 amRNSEnvestors announces its North strategy
16th May 20137:00 amRNSBraveheart's Envestors funds payasUgym
2nd May 20137:00 amRNSBraveheart announces Envestors funding for Loco2
22nd Apr 20137:00 amRNSEnvestors leads ComparaFinanza fundraising
15th Apr 20137:00 amRNSWhiteRock Capital Partners wins key industry award
12th Apr 20137:00 amRNSReorganisation of Yorkshire businesses
2nd Apr 20133:31 pmRNSDirectorate Change - amended
2nd Apr 20137:00 amRNSDirectorate Change
19th Mar 20137:00 amRNSAdviser change of name
22nd Feb 20133:45 pmRNSUpdate on WhiteRock and Growth Loan Fund -Amend
22nd Feb 20133:02 pmRNSUpdate on WhiteRock and Growth Loan Fund
21st Feb 20137:00 amRNSEnvestors closes funding for Cipher Surgical
4th Feb 20137:00 amRNSSubsidiary and office name change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.